NEI Podcast

Neuroscience Education Institute
undefined
Nov 17, 2023 • 12min

E206 - 2023 NEI Congress Extended Q&A: Anhedonia and Emotional Blunting with Dr. Vladimir Maletic

In this episode, Dr. Vladimir Maletic addresses your unanswered questions from his presentations, “From Despair to Delight: Advances in the Diagnosis and Treatment of Anhedonia” and “Ho Hum to Aha! Treating Anhedonia and Emotional Blunting.”
undefined
Nov 17, 2023 • 8min

E205 - 2023 NEI Congress Extended Q&A: Agitation in Dementia with Dr. Leslie Citrome

In this episode, Dr. Leslie Citrome addresses your unanswered questions from his presentation, There’s No Place Like Home: Addressing Agitation in Dementia.
undefined
Nov 16, 2023 • 60min

E204 - The PsychopharmaStahlogy Show: How Do Psychedelics Work Anyway? with Dr. Roger McIntyre

What is the role of the 5HT2A receptor in the therapeutic actions of psychedelics? What additional mechanisms may be involved in the therapeutic benefits of classic psychedelics? Is the psychedelic trip necessary for the therapeutic benefit of psychedelics?  Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on the role of psychedelics in modern psychiatry.  Today, Dr. Andy Cutler interviews Dr. Roger McIntyre and Dr. Stephen Stahl about the current understanding of the neurobiological mechanisms underlying the therapeutic benefits of psychedelics.  Let’s listen to Part 2 of our theme: Classic Psychedelics for the Modern Psychopharmacologist.  Subscribe to the NEI Podcast, so that you don’t miss another episode!   
undefined
Nov 11, 2023 • 17min

E203 - 2023 NEI Congress Extended Q&A: Neurology for Psychiatrists with Dr. Laxman Bahroo

In this episode, Dr. Laxman Bahroo addresses your unanswered questions from his presentation, Neurology for Psychiatrists.
undefined
Nov 11, 2023 • 22min

E202 - 2023 NEI Congress Extended Q&A: Therapeutic Potential of Psychedelics with Dr. Roger McIntyre

In this episode, Dr. Roger McIntyre addresses your unanswered questions from his presentation, Unveiling the Therapeutic Potential: Evidence Supporting the Use of Psychedelics for PTSD, SUD, and Other Indications, at the Pre-Conference Psychedelics Workshop.
undefined
Nov 11, 2023 • 16min

E201 - 2023 NEI Congress Extended Q&A: Juvenile Bipolar Disorder and ADHD with Dr. Timothy Wilens

In this episode, Dr. Timothy Wilens addresses your unanswered questions from his presentation, Double Trouble: Diagnosis and Pharmacotherapy of ADHD and Juvenile Bipolar Disorder, at the Child & Adolescent Psychiatry Academy.
undefined
Nov 10, 2023 • 15min

E200 - 2023 NEI Congress Extended Q&A: Autism Spectrum Disorder and Comorbidities with Dr. Robyn Thom

In this episode, Dr. Robyn Thom addresses your unanswered questions from her presentation, The Full Picture: Managing Autism Spectrum Disorder and Its Frequent Psychiatric Comorbidities, at the Child & Adolescent Psychiatry Academy.
undefined
Nov 10, 2023 • 13min

E199 - 2023 NEI Congress Extended Q&A: Comorbid Anxiety in Childhood with Dr. Jeffrey Strawn

In this episode, Dr. Jeffrey Strawn addresses your unanswered questions from his presentation, Along for the Ride: Treatment Considerations for Childhood Psychiatric Disorders With Co-Occurring Anxiety, at the Child & Adolescent Psychiatry Academy.
undefined
Nov 1, 2023 • 52min

E198 - Combating Stigma in Mental Health with Dr. Dawn Velligan

Stigma surrounding mental illness and its treatment can be pervasive and negatively impact the quality of life of patients suffering with mental health problems. What role do psychiatric healthcare providers play in addressing and combating mental illness stigma? How do cultural factors influence the perception of mental illness and stigma? What are the best strategies for reducing stigma related to mental illness? Dawn I. Velligan, PhD is a Professor in the Department of Psychiatry, Chief of the Division of Community Recovery, Research and Training, and the Henry B. Dielmann Chair at the University of Texas Health Science Center in San Antonio, Texas. Dr. Velligan’s internationally recognized research program focuses on the development and testing of psychosocial treatments to improve medication interest, follow-through, and outcomes for people with schizophrenia. She developed cognitive adaptation training; a treatment designed to improve functional outcomes for people with serious mental illness. Dr. Velligan is an author of numerous publications in high impact journals and has received grant funding from the National Institutes of Health, The National Alliance for Research on Schizophrenia and Depression, industry, and private foundations.
undefined
Oct 25, 2023 • 29min

E197 - 2023 NEI Congress Preview

The 19th annual NEI Congress is upon us. Whether you’ve already secured your spot to join us in person at The Broadmoor in Colorado Springs or plan to attend virtually via simulcast OR are still unsure if this event is for you, you’re in luck. This is our Congress preview episode.  Congress chairman, Dr. Andrew Cutler interviews a few of the brilliant faculty members who will be speaking at this year’s conference for a sneak peek of their presentations and finds out what they are looking forward to at the upcoming event. Register now for 2023 NEI Congress at: https://nei.global/23cng-REG_neipod

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app